• Novobiocin Workflows: Applied Protocols for Antimicrobial Re

  2026-05-20

  Novobiocin, a potent aminocoumarin antibiotic, unlocks precision in antibacterial, antiparasitic, and antiviral research. This article offers actionable workflows, protocol enhancements, and troubleshooting insights, bridging advanced bench techniques with the latest structural findings for resistance and apoptosis assay development.

• Phosphatase Inhibitor Cocktail 1 (100X in DMSO): Practical U

  2026-05-19

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) addresses the critical need to preserve protein phosphorylation during sample preparation, preventing dephosphorylation by endogenous phosphatases. It is recommended for workflows such as Western blotting and phosphoproteomic analysis, but should not be used in diagnostic or therapeutic applications.

• PP2A-Driven Autophagy Promotes Candida albicans Biofilm Resi

  2026-05-19

  This study demonstrates that protein phosphatase 2A (PP2A) mediates drug resistance in Candida albicans biofilms via autophagy induction, specifically through ATG protein phosphorylation. The findings reveal a mechanistic link between autophagy activation and antifungal resistance, offering new directions for therapeutic strategies targeting biofilm-associated infections.

• Niclosamide: Applied STAT3 Inhibition in Cancer Research Wor

  2026-05-18

  Niclosamide (5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide) enables reproducible STAT3 pathway inhibition and apoptosis studies in cancer models. This guide offers actionable workflow enhancements, troubleshooting strategies, and practical insights for robust in vitro and in vivo results.

• Gentamycin Sulfate: Mechanisms, Resistance, and Translationa

  2026-05-18

  This thought-leadership article provides translational researchers with a mechanistic and strategic roadmap for deploying Gentamycin Sulfate in bacterial protein synthesis research and the study of antibiotic resistance. By integrating recent epidemiological insights from multi-hospital studies with workflow optimization guidance, it highlights how APExBIO’s high-purity Gentamycin Sulfate enables robust, reproducible, and clinically relevant research on emerging Gram-negative threats.

• Cytoskeleton-Dependent Autophagy Triggered by Mechanical Str

  2026-05-17

  This study establishes that the cellular cytoskeleton, primarily microfilaments, is essential for autophagy induction in response to compressive mechanical forces. The findings clarify mechanotransduction pathways and provide new experimental direction for dissecting cytoskeleton-calcium interactions in autophagy and cell stress models.

• Cl-Amidine Trifluoroacetate Salt: PAD4 Inhibition Evidence &

  2026-05-16

  Cl-Amidine (trifluoroacetate salt) is a potent, selective PAD4 inhibitor with an IC50 of 5.9 μM. It is a critical tool in cancer and rheumatoid arthritis research, enabling precise modulation of histone citrullination and neutrophil extracellular trap formation. This article details its evidence base, biochemical specificity, and application limits.

• Eltanexor Inhibits XPO1 to Suppress Wnt/β-Catenin in CRC Mod

  2026-05-15

  This study demonstrates that Eltanexor, a second-generation XPO1 inhibitor, effectively reduces colorectal cancer (CRC) tumorigenesis by modulating the Wnt/β-catenin pathway and suppressing COX-2 expression. The findings highlight XPO1 inhibition as a promising chemopreventive strategy for high-risk CRC populations, with translational implications for both preclinical and clinical research.

• CGP 55845 Hydrochloride: Optimizing GABAB Antagonist Assays

  2026-05-15

  Leverage CGP 55845 hydrochloride for targeted, reproducible GABAB receptor antagonist workflows in synaptic transmission research. This guide translates cutting-edge glial-neuronal modulation insights into actionable protocol improvements and troubleshooting strategies for in vitro neuroscience.

• Adenosine Triphosphate (ATP): Precision Tools for Mitochondr

  2026-05-14

  Explore how Adenosine Triphosphate (ATP) advances mitochondrial proteostasis research through its dual roles in energy metabolism and post-translational regulation. This in-depth article uniquely connects ATP’s biochemical precision to practical assay design, bridging mechanistic insight with reagent selection.

• Pioglitazone: PPARγ Agonist for Macrophage Polarization Stud

  2026-05-14

  Pioglitazone from APExBIO stands out as a robust PPARγ agonist for dissecting immune-metabolic mechanisms in chronic inflammation and metabolic disorder research. Advanced workflows and troubleshooting strategies empower precise modeling of macrophage polarization, insulin resistance, and neuroprotection.

• Fingolimod (FTY720): S1P Receptor Modulator for Multiple Scl

  2026-05-13

  Fingolimod (FTY720) is an oral sphingosine-1-phosphate receptor modulator FDA-approved for multiple sclerosis. It inhibits lymphocyte egress, modulates CNS signaling, and demonstrates neuroprotection via BDNF upregulation. APExBIO supplies high-purity Fingolimod (A8548) optimized for research workflows.

• Streptavidin – Cy5: Precision Biotin Detection for IF & Flow

  2026-05-13

  Streptavidin – Cy5 enables ultra-sensitive, quantitative biotin detection across immunofluorescence and flow cytometry workflows. Its Cy5 fluorescent dye conjugation delivers high signal-to-noise and multiplexing capacity for demanding cell and tissue assays. Discover protocol enhancements and troubleshooting tips validated in recent cancer research.

• Synergistic Caspase-8 Activation by Hyperthermia and Cisplat

  2026-05-12

  The referenced study elucidates how hyperthermia combined with cisplatin uniquely enhances caspase-8 accumulation and activation in cancer cells, driving both apoptosis and pyroptosis. This mechanistic insight advances understanding of programmed cell death and suggests new avenues for optimizing combination cancer therapies.

• ETS1 Regulates Mitophagy via SENP2/HSPA8/FUNDC1 in BPD Model

  2026-05-12

  This study identifies ETS1 as a transcriptional regulator that mitigates mitochondrial damage-induced autophagy in bronchopulmonary dysplasia (BPD) by modulating the SENP2/HSPA8/FUNDC1 axis. The findings illuminate a new mechanistic pathway for targeted autophagy research in pulmonary disease.

566 records 10/38 page Previous Next First page 上5页 678910 下5页 Last page